Metropolitan Life Insurance Company (MetLife)’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-5,222
| Closed | -$43.3K | – | 1681 |
|
2024
Q1 | $43.3K | Hold |
5,222
| – | – | ﹤0.01% | 1481 |
|
2023
Q4 | $57.5K | Hold |
5,222
| – | – | ﹤0.01% | 1372 |
|
2023
Q3 | $43.9K | Buy |
5,222
+384
| +8% | +$3.23K | ﹤0.01% | 1481 |
|
2023
Q2 | $60.8K | Hold |
4,838
| – | – | ﹤0.01% | 1312 |
|
2023
Q1 | $79.7K | Sell |
4,838
-426
| -8% | -$7.02K | ﹤0.01% | 1122 |
|
2022
Q4 | $78.6K | Buy |
5,264
+706
| +15% | +$10.5K | ﹤0.01% | 1202 |
|
2022
Q3 | $102K | Hold |
4,558
| – | – | ﹤0.01% | 1007 |
|
2022
Q2 | $76.3K | Hold |
4,558
| – | – | ﹤0.01% | 1224 |
|
2022
Q1 | $136K | Sell |
4,558
-13,536
| -75% | -$405K | ﹤0.01% | 1009 |
|
2021
Q4 | $556K | Buy |
18,094
+1,810
| +11% | +$55.6K | 0.01% | 1357 |
|
2021
Q3 | $513K | Hold |
16,284
| – | – | 0.01% | 1444 |
|
2021
Q2 | $596K | Buy |
16,284
+3,453
| +27% | +$126K | 0.01% | 1403 |
|
2021
Q1 | $444K | Buy |
12,831
+3,406
| +36% | +$118K | 0.01% | 1499 |
|
2020
Q4 | $392K | Hold |
9,425
| – | – | 0.01% | 1521 |
|
2020
Q3 | $401K | Buy |
+9,425
| New | +$401K | 0.01% | 1362 |
|